Cargando…
Review of extended-release formulations of Tramadol for the management of chronic non-cancer pain: focus on marketed formulations
Patients with chronic non-malignant pain report impairments of physical, social, and psychological well-being. The goal of pain management should include reducing pain and improving quality of life. Patients with chronic pain require medications that are able to provide adequate pain relief, have mi...
Autores principales: | Kizilbash, Arshi, Ngô-Minh, Cường |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968086/ https://www.ncbi.nlm.nih.gov/pubmed/24711710 http://dx.doi.org/10.2147/JPR.S49502 |
Ejemplares similares
-
Chronic non-cancer pain: Focus on once-daily tramadol formulations
por: Coluzzi, Flaminia, et al.
Publicado: (2007) -
Tramadol extended-release in the management of chronic pain
por: McCarberg, Bill
Publicado: (2007) -
Tramadol Extended-Release for the Management of Pain due to Osteoarthritis
por: Angeletti, Chiara, et al.
Publicado: (2013) -
Newly developed controlled release subcutaneous formulation for tramadol hydrochloride
por: Mabrouk, Mostafa, et al.
Publicado: (2018) -
A new extended release formulation (OROS(®)) of hydromorphone in the management of pain
por: Weinstein, Sharon M
Publicado: (2009)